CHF120.20
0.33%
SIX Swiss Exchange, Jun 10, 05:31 pm CET
ISIN
CH0030486770
Symbol
DAE
Sector
Industry

Dätwyler Stock price

CHF120.20
-1.80 1.48% 1M
-20.40 14.51% 6M
-13.00 9.76% YTD
-70.20 36.87% 1Y
-56.40 31.94% 5Y
-13.60 10.16% 10Y
-313,102.80 99.96% 20Y
SIX Swiss Exchange, Closing price Tue, Jun 10 2025
+0.40 0.33%
ISIN
CH0030486770
Symbol
DAE
Sector
Industry

Key metrics

Market capitalization CHF2.04b
Enterprise Value CHF2.48b
P/E (TTM) P/E ratio 65.68
EV/FCF (TTM) EV/FCF 19.48
EV/Sales (TTM) EV/Sales 2.24
P/S ratio (TTM) P/S ratio 1.84
P/B ratio (TTM) P/B ratio 5.55
Dividend yield 2.67%
Last dividend (FY24) CHF3.20
Revenue growth (TTM) Revenue growth -3.80%
Revenue (TTM) Revenue CHF1.11b
EBIT (operating result TTM) EBIT CHF80.20m
Free Cash Flow (TTM) Free Cash Flow CHF127.50m
Cash position CHF127.40m
EPS (TTM) EPS CHF1.83
P/E forward 27.58
P/S forward 1.83
EV/Sales forward 2.23
Show more

Is Dätwyler a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,838 stocks worldwide.

Dätwyler Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Dätwyler forecast:

1x Buy
50%
1x Hold
50%

Analyst Opinions

2 Analysts have issued a Dätwyler forecast:

Buy
50%
Hold
50%

Financial data from Dätwyler

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,108 1,108
4% 4%
100%
- Direct Costs 869 869
5% 5%
78%
238 238
1% 1%
22%
- Selling and Administrative Expenses 100 100
1% 1%
9%
- Research and Development Expense 43 43
3% 3%
4%
171 171
15% 15%
15%
- Depreciation and Amortization 91 91
13% 13%
8%
EBIT (Operating Income) EBIT 80 80
33% 33%
7%
Net Profit 31 31
53% 53%
3%

In millions CHF.

Don't miss a Thing! We will send you all news about Dätwyler directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Dätwyler Holding AG engages in the supply of system-critical elastomer components for injectable drug delivery systems. It operates through the Healthcare Solutions and Industrial Solutions segments. The Healthcare Solutions segment offers system-critical components for containers and delivery systems for injectable drugs and diagnostics in the pharmaceutical and medical markets. The Industrial Solutions segment manufactures customized system-critical components for applications in the mobility, food, and beverage, and general industry markets. The company was founded in 1915 and is headquartered in Altdorf, Switzerland.

Head office Switzerland
CEO Volker Cwielong
Employees 8,030
Founded 1915
Website www.datwyler.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today